جستجوی استاد راهنمای دانشگاهی

Richard O'Connorمشاهده پروفایل

استادیار

• Neuroscience
• Psychiatric Disorders
• Addiction
• +۷ مورد دیگر

Dr. Richard O'Connor is an Assistant Professor at the Icahn School of Medicine, affiliated with the Department of Neuroscience and the Friedman Brain Institute at Mount Sinai. His research bridges neuropharmacology and psychiatric disorders, focusing on mechanisms underlying addiction, obesity, and mood disorders. Institution: Icahn School of Medicine at Mount Sinai Department: Department of Neuroscience Email: richard.oconnor@mssm.edu Research Interests Dr. O'Connor's work explores: Neuroepigenetic mechanisms (e.g., histone dopaminylation) MicroRNA dynamics in psychiatric pathophysiology Dopamine signaling in compulsive behaviors Overlap between substance use disorders and eating behaviors Translational approaches to addiction and obesity Mental health biomarker discovery Scientific Trends Analysis of his 2016-2022 publications reveals consistent focus on: Neurobiological intersections between addiction and obesity Epigenetic modifications in reward circuits miRNA-based diagnostic approaches Translational models of compulsive behaviors Neuropharmacological targets for intervention Behavioral neuroscience methodologies Media Engagement He has been featured in press coverage discussing: Opioid addiction neurobiology (2024) Neuroepigenetic mechanisms in addiction (2024) Exercise and multiple sclerosis management (2023)

Phillip Kantharidisمشاهده پروفایل

پژوهشگر ارشد

• Diabetes
• Diabetic Complications
• Diabetic Nephropathy
• +۱۲ مورد دیگر

Dr. Phillip Kantharidis is a Senior Research Fellow at Monash University, affiliated with the Department of Diabetes within the School of Clinical Sciences. He leads an active research group focused on diabetic complications, particularly nephropathy and atherosclerosis, and is accepting PhD students for projects on pro-resolution therapies and lipoxin A4. PhD in Molecular Biology, University of Melbourne (1993) BSc (Hons) in Virology, University of Melbourne (1983) His research centers on the interplay between genetic, fibrotic, and inflammatory factors in diabetes. Key interests include cytokines, growth factors, microRNAs, and endogenous molecules like resolvins and lipoxin A4, which modulate pathological signaling. His lab uses RNA-seq to identify predictive biomarkers in biological fluids. These efforts aim to develop novel treatments targeting multiple diabetic complications. The 15 most recent publications highlight a strong focus on diabetic kidney disease and cardiovascular dysfunction, with emerging themes in inflammation resolution, microRNA regulation, and therapeutic analogues. Articles are published in high-impact journals such as Kidney International , Cardiovascular Diabetology , and International Journal of Molecular Sciences , demonstrating translational and mechanistic depth. Dr. Kantharidis has contributed to significant research outputs, including articles, reviews, and commentaries, with recent work gaining attention in news outlets and social media. While no specific awards are listed, his work is recognized through citations and collaborative projects. He serves as a Chief Investigator on research grants, including a completed project on a novel endogenous inhibitor for diabetic nephropathy. He mentors PhD students and collaborates extensively with researchers such as Professor Merlin Cooper. His laboratory, the Kantharidis Group, is a key contributor to diabetes research at Monash, with a focus on molecular mechanisms and therapeutic innovation. His research contributes to the UN Sustainable Development Goals, particularly in advancing health and well-being through biomedical innovation.

Mosavar Farahaniمشاهده پروفایل

مدرس ارشد

• Biomedical Science
• Exosomal microRNA
• Haematological Malignancies
• +۱۲ مورد دیگر

Dr. Mosavar Farahani is a Senior Lecturer in Biomedical Science at the University of Northampton, affiliated with the Science Centre for Physical Activity and Life Sciences. She is actively involved in research on exosomal microRNAs in haematological malignancies and is accepting PhD students. Her work is highly collaborative, involving clinical and academic partners such as the Northwest Anglia NHS Foundation Trust and the University of Liverpool. Her research focuses on the role of microRNAs in cancer, particularly as non-invasive prognostic biomarkers in chronic lymphocytic leukaemia (CLL) and multiple myeloma. She also explores the potential of exosomal microRNAs as drug delivery vehicles in neurological diseases, highlighting an interdisciplinary approach bridging oncology and neurology. Recent publications and research outputs demonstrate a consistent focus on microRNA expression, tumor signaling, and clinical biomarker discovery. Her work spans from molecular mechanisms in CLL to translational studies in plasma cell malignancies, showing a strong trend in biomarker validation and exosome-mediated intercellular communication. Scientific contributions include: Membership in the British Society for Haematology (2021) Membership in the Research Institute of Biomedical Science (IBMS) (2021) Dr. Farahani has led two significant research projects: one internal pilot study on plasma microRNA profiling in plasma cell malignancies (2022), and a charitable-funded project investigating plasma Galectin-3 and RANKL in multiple myeloma progression (2023–2024). These projects reflect her leadership in translational research and grant acquisition. Her collaborations with Professor Lugan Yu and NHS partners underscore her role in bridging laboratory findings with clinical applications. She is affiliated with active research networks and maintains an ORCID profile (0000-0002-5814-2584), with publications cited across platforms like Mendeley and referenced in patents, indicating impact beyond academia.

Grant Wheelerمشاهده پروفایل

استاد

• Cell and Developmental Biology
• Wnt Signalling
• Neural Crest Development
• +۱۰ مورد دیگر

Grant Wheeler is a Professor in the School of Biological Sciences at the University of East Anglia (UEA), where he leads the Wheeler Group and conducts research in cell and developmental biology. He is also a member of the Cells and Tissues research group and serves as the BIO Open Lecture Coordinator. His research primarily uses the amphibian model organism Xenopus laevis to study molecular mechanisms in embryonic development. Professor in Cell and Developmental Biology, University of East Anglia (2020–present) Reader in Cell and Developmental Biology (2015–2020) Senior Lecturer (2010–2014) Lecturer (2001–2009) Postdoctoral Research Associate at University of Dundee and MIT (1996–2001) PhD from N.I.M.R., Mill Hill, London (1992–1996) BSc in Biochemistry, King's College London (1988–1991) His research focuses on the molecular regulation of cell type origin and migration during embryogenesis. Key areas include Wnt signaling, neural crest development, microRNA function, cell adhesion/migration via matrix metalloproteinases and ADAMs, and chemical genetic screens for melanoma therapeutics. He employs modern embryological and molecular biology techniques in Xenopus to study these processes in a whole-animal context. The most recent publications highlight his group’s expertise in gene regulation, CRISPR-based functional genomics, and Wnt signaling across model systems. Articles published in Nature Communications and Bone Research demonstrate ongoing contributions to understanding developmental signaling and regeneration. His work bridges fundamental developmental biology with translational applications in skeletal disorders and cancer. Grant Wheeler is actively involved in mentoring and training. He welcomes PhD students and postdoctoral researchers, supporting applications for fellowships such as EMBO and Marie Curie. He collaborates closely with Professor Andrea Munsterberg and participates in joint lab meetings and seminars. He also encourages lab members to attend international conferences and training courses. He has secured multiple research grants from prestigious funders including the Biotechnology and Biological Sciences Research Council (BBSRC), the National Centre for the 3Rs, the Royal College of Surgeons of England, and the Company of Biologists. Current projects include functional analysis of alkylglycerol monooxygenase in Wnt signaling, neural crest disorders, combinatorial melanoma therapies, and cardiotoxicity screening tools. Wheeler is an active member of the scientific community, serving as an Ambassador for the British Society for Cell Biology since 2010. His work has been featured in news outlets, blogs, and social media platforms, and has been referenced in patents, indicating broader scientific and translational impact.

Gale Strasburgمشاهده پروفایل

استاد

• Muscle Biology
• Food Safety
• Carcinogen Studies
• +۳ مورد دیگر

Gale Strasburg is a Professor in the Department of Food Science and Human Nutrition at Michigan State University. His research focuses on molecular mechanisms of muscle growth and development, particularly in avian species, and the impact of environmental stressors like thermal challenges on muscle physiology. He is also a leading expert in aflatoxin contamination in agricultural products, including sunflower seeds, and its implications for food safety and human health. Dr. Strasburg holds an M.S. and Ph.D. in Muscle Biology from the University of Wisconsin-Madison, followed by postdoctoral training at the Boston Biomedical Research Institute. His work integrates genomics, cell biology, and food science to address challenges in meat quality, muscle disorders, and mycotoxin mitigation. Research interests include the molecular basis of muscle development, thermal stress effects on satellite cells, and the detection/prevention of aflatoxin in agricultural commodities. His lab has pioneered studies linking aflatoxin in sunflower seeds to liver carcinogenesis, with implications for global food safety. Key trends in his publications (2017–2025) emphasize thermal stress effects on avian muscle cells, genomic responses to environmental challenges, and omics-driven approaches to food safety. He has extensively studied lipid metabolism, signaling pathways (mTOR, Wnt), and RNA regulation in muscle development. Labs/Teams: The Strasburg Laboratory at MSU focuses on interdisciplinary research at the intersection of food science, molecular biology, and agricultural safety. No notable awards or grants are explicitly listed in the provided text.

Mariappan Muthuchamyمشاهده پروفایل

استاد

• Cardiac Muscle Physiology
• Lymphatic System Biology
• Mechanotransduction
• +۴ مورد دیگر

Mariappan Muthuchamy is a Professor of Medical Physiology and Director of the Cardiovascular Research Institute at Texas A&M University. His research focuses on cardiac and lymphatic muscle contraction mechanisms, mechanotransduction signaling, and the interplay between mechanical forces and cellular functions. He holds the Lyndon Baines Johnson Research Award. Education: B.S. Chemistry, Madurai Kamaraj University, India (1980) M.S. Biochemistry, Madurai Kamaraj University, India (1983) Ph.D. Biochemistry/Molecular Biology, Madurai Kamaraj University, India (1991) Research Interests: Dr. Muthuchamy’s work explores molecular mechanisms underlying cardiac muscle dynamics in health and disease, including thin filament activation, crossbridge kinetics, and mechanotransduction. His lab employs molecular, cellular, and structural techniques to study myofilament regulation. He pioneered methods to exchange myofibrillar proteins via transgenic manipulation. Additionally, he investigates lymphatic muscle contraction, its role in fluid transport, and its unique smooth-striated hybrid contractile properties. Recent work includes studying lymphatic dysfunction in metabolic disorders and inflammatory conditions using advanced tools like Atomic Force Microscopy (AFM) and microphysiological systems (e.g., Lymphangion-Chip). Key Findings: Established AFM-fluorescence microscopy fusion for mechanotransduction studies. Discovered lymphatic muscle’s role in systemic fluid dynamics and disease pathogenesis (e.g., lymphedema, metabolic syndrome). Linked inflammatory mediators (e.g., IL-1β, TNF-α) to lymphatic pump impairment. Awards: Lyndon Baines Johnson Research Award (Lyndon Baines Johnson Foundation) Lab & Collaborations: His lab includes Research Assistant Akshaya Narayanan (akshaya.narayanan@tamu.edu). Collaborations focus on translational research in cardiovascular and lymphatic physiology, leveraging engineered tissues and animal models. Ongoing projects target lymphatic dysfunction in amyotrophic lateral sclerosis, Duchenne muscular dystrophy, and metabolic diseases. Labs/Teams: Cardiovascular Research Institute (CRI) at Texas A&M, with interdisciplinary teams studying mechanobiology, integrin signaling, and lymphatic-inflammatory interactions.

Chantal Matarمشاهده پروفایل

استاد

• Probiotics
• Cancer Research
• Cell Signaling
• +۳ مورد دیگر

Chantal Matar is a Full Professor specializing in Nutrition Sciences, focusing on probiotics, cancer research, and immunomodulation. Her work integrates microbiology, molecular biology, and dietary interventions to address cancer stem cells, inflammation, and epigenetic mechanisms. Key research areas include the development of probiotic bacteria (e.g., Rouxiella badensis ), polyphenol-enriched foods (e.g., blueberries), and their roles in preventing cancers (breast, skin, reproductive systems) and mitigating immune dysregulation. She explores age- and sex-specific effects of probiotics on pubertal immune responses and neurobehavioral outcomes. Her studies often involve miRNA regulation, gut-brain axis interactions, and preclinical models of inflammation and cancer. Collaborative efforts focus on translational applications of probiotics and fermented foods in clinical settings. Recent work highlights synergies between dietary interventions and epigenetic modulation, with implications for personalized nutrition and oncology.

Linda J. Hongمشاهده پروفایل

دانشیار

• Gynecologic Oncology
• Radiation Therapy Techniques
• Clinical Trials
• +۳ مورد دیگر

Linda J. Hong, MD is an Associate Professor in the Department of Gynecology & Obstetrics at Loma Linda University School of Medicine. Her research focuses on radiation oncology techniques, gynecologic malignancies, and clinical trials. She holds an MD from Saint Louis University (2008) and has contributed to over 110 peer-reviewed publications. Her research interests include optimizing radiation therapy methods for breast and gynecologic cancers, exploring genetic testing disparities in underserved populations, and investigating treatment toxicities. Notable projects include studies on dexamethasone regimens for chemotherapy hypersensitivity and surface-guided radiotherapy workflows. Dr. Hong leads or participates in multiple clinical trials, including SWOG-sponsored studies on PARP inhibitors, targeted therapies, and radiation techniques. She collaborates with multidisciplinary teams in radiation oncology, anesthesiology, and global health initiatives. Her work emphasizes patient-centered outcomes, cultural adaptation of medical tools, and improving care equity. Current projects address placenta accreta management, opioid reduction strategies, and environmental factors in gynecologic cancers.

Julia Unternaehrerمشاهده پروفایل

دانشیار

• Cancer Biology
• Developmental Biology
• Molecular Oncology
• +۳ مورد دیگر

Julia Unternaehrer is an Associate Professor in the Basic Sciences and Biochemistry Division, as well as in Gynecology & Obstetrics at Loma Linda University School of Medicine. She serves as Vice Chair of Basic Sciences and Co-Program Director for Cancer, Developmental, and Regenerative Biology programs. Her research focuses on the interplay between epithelial-mesenchymal transition (EMT) factors, microRNAs, and cancer stem cells in ovarian cancer progression and resistance mechanisms. She holds a PhD from Yale University (2004) and a BS from Loma Linda University (1987). Research Interests : Dr. Unternaehrer investigates how EMT pathways and microRNAs regulate cancer cell behavior, particularly in ovarian and prostate cancers. Her lab uses patient-derived xenograft models to study therapeutic resistance and stemness. Key areas include the Snail/let-7 axis in metastasis, radiation effects on cancer aggressiveness, and health disparities in genetic testing access. Grants & Service : She leads several grants including NIH-funded studies on chemoresistance and proton radiation impacts. She directs the Flow Cytometry and Patient-Derived Xenograft Core Facilities. Her service roles include thesis committee leadership for over a dozen students and committee memberships in academic affairs and institutional biosafety. Labs & Teams : Her research group collaborates on projects involving stem cell reprogramming, tumor microenvironment analysis, and translational oncology. Current initiatives target novel combination therapies for BRCA-associated cancers and disparities in Latinx patient outcomes.

Jason Eriksenمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Dementia
• Translational Research
• +۳ مورد دیگر

Jason Eriksen is an Associate Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy . He serves as Assistant Dean for Graduate Programs and is an Affiliate Member of the UH Center for Nuclear Receptors . Education: B.S. in Biology and English, Wake Forest University Ph.D. in Neuroscience, Loyola University Chicago Postdoctoral Fellowship, Mayo Clinic Dr. Eriksen's research focuses on Alzheimer's disease and dementia , investigating mechanisms of neurodegeneration and translational approaches for early detection and treatment. His work spans molecular neuroscience, amyloid plaque imaging, and therapeutic development. Scientific Awards: National Academy of Inventors, Senior Member (2020) University of Houston Excellence in Research (2014)

Richard Keijzerمشاهده پروفایل

استاد

• Pediatric Surgery
• Congenital Anomalies
• Congenital Diaphragmatic Hernia (CDH)
• +۷ مورد دیگر

Dr. Richard Keijzer is a Professor in the Department of Surgery at the University of Manitoba's Max Rady College of Medicine. He holds cross-appointments in Pediatrics and Child Health, and Physiology and Pathophysiology. As the Thorlakson Chair in Surgical Research and Director of Research for Surgery, he bridges clinical practice with laboratory innovation in pediatric surgery. Education: MD, PhD, and MSc from ErasmusMC (Netherlands); fellowships in Toronto and Alabama Research: Focuses on congenital diaphragmatic hernia (CDH), lung development, microRNAs, and prenatal therapies Leadership: Chair of Canadian Child Health Clinician Scientist Program Selection Committee; 2018 Site Director for Surgery at HSC-Children’s Hospital His work combines microRNA/circRNA mechanisms with minimal-invasive pediatric surgery , aiming to translate discoveries from bench to bedside. Recent publications address CDH biomarkers , prenatal interventions , and clinical trial methodologies . Awards: 2021 Travelling Fellow, James IV Association of Surgeons 2020 Pediatric Chairs of Canada Leadership Award 2013 CIHR/Manitoba Lung Association/CHRIM New Investigator Award 2012 Canadian Child Health Clinician Scientist Career Development Award As a pediatric surgeon-scientist, he integrates clinical expertise with experimental research through the Biology of Breathing theme at CHRIM and the Congenital Diaphragmatic Hernia Study Group. His lab's 2023 work on circRNA biomarkers and miR-200b prenatal therapy exemplifies his translational approach.

Mireille Ouimetمشاهده پروفایل

دانشیار

• Cardiovascular Diseases
• Atherosclerosis
• Cellular Immunometabolism
• +۴ مورد دیگر

Dr. Mireille Ouimet is an Associate Professor at the Department of Biochemistry, Microbiology and Immunology within the Faculty of Medicine at the University of Ottawa. Her research focuses on cardiovascular diseases, particularly atherosclerosis, integrating immunometabolism and autophagy pathways to develop novel therapeutic strategies. BSc Biochemistry, University of Ottawa PhD Biochemistry, University of Ottawa Postdoctoral Fellowship, New York University Dr. Ouimet's work explores autophagy-mediated lipid droplet degradation (lipophagy) as a mechanism to reverse atherosclerotic plaques, with emphasis on cholesterol homeostasis, miRNA regulation, and macrophage metabolism. Her laboratory investigates the molecular components of lipophagy for therapeutic manipulation. Recent publications highlight her contributions to understanding miRNA-controlled lipid metabolism, autophagy in atherosclerosis, and mitochondrial energy status in macrophage polarization. Collaborative studies involve nanoparticle-based imaging and immunometabolic reprogramming in cardiovascular disease.

Yvonne Lin-Liuمشاهده پروفایل

استاد بالینی

• Gynecologic Oncology
• Endometrial Cancer
• Ovarian Cancer
• +۳ مورد دیگر

Dr. Yvonne Lin-Liu is a Board Certified Gynecologic Oncologist and Staff Physician in the Division of Gynecologic Oncology within the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco (UCSF). She specializes in treating gynecologic cancers with a patient-centered approach, focusing on helping patients understand their disease biology and available treatment options, particularly serving women seeking second opinions. Dr. Lin-Liu's educational background includes: SB in Chemistry from Massachusetts Institute of Technology (1993) MS in Epidemiology from Harvard School of Public Health (1995) MD from University of California-Irvine College of Medicine (2001) Residency in Obstetrics & Gynecology from Beth Israel Deaconess Medical Center (2005) Fellowship in Gynecologic Oncology from The University of Texas M.D. Anderson Cancer Center (2009) Her research focuses on molecular mechanisms of gynecologic cancers, particularly examining the role of glucose-regulated protein-78 (GRP78), AKT signaling pathways, and the impact of obesity on cellular stress in endometrial cancer development. She has investigated natural compounds like curcumin for cancer treatment and explored the relationship between chronic stress and cancer progression. Her work bridges basic science discoveries with clinical applications to improve patient outcomes. Analysis of her publication record reveals a consistent trajectory in gynecologic oncology research, with emphasis on molecular pathways in endometrial and ovarian cancers. Her work spans from fundamental molecular investigations to clinical studies examining treatment patterns, demonstrating an integrated approach to cancer research that connects laboratory findings with patient care considerations. Dr. Lin-Liu has received significant recognition for her contributions to the field: NIH/NCI Career Development Award (2013) Gynecologic Cancer Foundation/St. Louis Ovarian Cancer Awareness Research Award (2011) Dr. Lin-Liu was previously an NCI-funded physician-scientist at UCSF studying obesity's impact on endometrial cancer before joining Genentech in 2014 as a Group Medical Director. Despite her industry role, she maintains active clinical practice, believing direct patient care is essential to developing effective cancer therapies. She serves on various professional society committees focused on development and editorial boards of prominent journals, demonstrating ongoing commitment to academic medicine. She is an active member of the Society of Gynecologic Oncology, Western Association of Gynecologic Oncologists, American Association for Cancer Research, and American Society of Clinical Oncology, contributing to the broader cancer research community through these professional affiliations.

• Clinical Pharmacology
• Drug Formularies
• Statin-induced Myopathy
• +۴ مورد دیگر

Marie-Louise Ovesjö is an Affiliated Researcher at the Department of Laboratory Medicine, Division of Clinical Pharmacology at Karolinska Institutet in Stockholm, Sweden. She works in affiliation with Karolinska University Hospital, with visiting address at Avd.För klinisk Farmakologi C1:68, Karolinska Universitetssjukhuset, and postal address at H5 Laboratoriemedicin, H5 Klin Farmakologi, 141 52 Huddinge. Her current employment period spans from 2022 to 2025. Her educational background includes: Doctor of Philosophy from the Department of Neuroscience, Karolinska Institutet (2000) University Medical Degree from Karolinska Institutet (1996) Dr. Ovesjö's research demonstrates a dual trajectory spanning both neuropharmacology and clinical pharmacology. Her early work (2000-2003) focused on leptin receptors in the hypothalamus and their role in body weight regulation, investigating GABAergic systems and glutamate transporters. Her more recent research (2009-present) centers on clinical pharmacology applications, particularly the evaluation and implementation of the 'Wise List' - Stockholm's drug and therapeutic committee recommendations for essential medicines. She has conducted extensive research on statin-induced myopathy, exploring vitamin D levels, genetic polymorphisms, and ubiquinone as potential risk factors. Additionally, she has contributed significantly to the development and evaluation of clinical decision support systems, particularly the SFINX drug-drug interaction database. Her publication analysis reveals a consistent focus on improving medication safety and rational drug use in clinical practice. The earlier neuropharmacology work established foundational knowledge about body weight regulation mechanisms, while her clinical pharmacology research has directly influenced medication policy and practice in Stockholm. Her studies on the 'Wise List' demonstrate high adherence rates and physician trust in evidence-based drug recommendations, while her statin research provides valuable insights into managing adverse drug reactions in real-world settings. Dr. Ovesjö has maintained strong collaborative relationships throughout her career, frequently working with the Stockholm Drug and Therapeutic Committee and colleagues across Karolinska Institutet. Her research bridges basic pharmacological science with practical clinical applications, focusing on how healthcare providers and patients interact with medication guidelines and decision support tools.

Konstantinos Kapnisisمشاهده پروفایل

استاد آموزشی

• Biomedical Engineering
• Cardiovascular Biomechanics
• Biomaterials
• +۷ مورد دیگر

Dr. Konstantinos Kapnisis is a Teaching Professor at the Cyprus University of Technology, serving as Lab Manager of the BioLISYS lab. He holds a Diploma in Applied Mathematical and Physical Sciences from the National Technical University of Athens, an MSc from Imperial College London, and a PhD from CUT's Department of Mechanical Engineering and Materials Science and Engineering. His research focuses on biomedical engineering and implant biocompatibility , with expertise in in vivo modeling of cardiovascular and cancer diseases. He specializes in microsurgical procedures in mice and toxicokinetic modeling for implant safety assessments. Developed animal models for implant biocompatibility Advanced PBTK frameworks for cardiovascular devices Investigated stent-induced inflammation and miRNA therapies Scientific Awards: Cyprus State Scholarship Foundation fellowship (2008-2011) A.G. Leventis Foundation scholarship (2011-2013, 2012-2013) Grants: Secured €350,000+ in funding from the Cyprus Research and Innovation Foundation through highly ranked grants including POST-DOC/0916/0237 and INTERNATIONAL/USA/0118/0057.